KMTS
KMTS
NASDAQ · Health Care

Kestra Medical Technologies

$20.58
-0.12 (-0.58%)
As of Mar 25, 10:01 PM ET ·
Financial Highlights (FY 2026)
Revenue
70.64M
Net Income
-134,397,895
Gross Margin
40.5%
Profit Margin
-190.3%
Rev Growth
D/E Ratio
0.20
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 40.5% 51.6% 51.6% 51.6%
Operating Margin -177.8% 19.2% 19.0% 18.4%
Profit Margin -190.3% 13.2% 16.0% 14.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 70.64M 467.86M 451.21M 384.70M
Gross Profit 28.59M 241.42M 232.82M 198.50M
Operating Income -125,625,010 89.79M 85.79M 70.89M
Net Income -134,397,895 61.58M 72.02M 57.24M
Gross Margin 40.5% 51.6% 51.6% 51.6%
Operating Margin -177.8% 19.2% 19.0% 18.4%
Profit Margin -190.3% 13.2% 16.0% 14.9%
Rev Growth +24.3% -1.3% +10.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 95.67M 164.83M 164.09M 153.25M
Total Equity 478.14M 1.08B 950.20M 957.14M
D/E Ratio 0.20 0.15 0.17 0.16
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -119,476,494 118.92M 127.55M 105.65M
Free Cash Flow 46.82M 46.49M 55.42M